(Q37532139)

20 August 2017

1 reference

title

Epileptic seizures in AD patients (English)

1 reference

20 August 2017

0 references

A J Larner

1

1 reference

20 August 2017

26 June 2009

1 reference

20 August 2017

NeuroMolecular Medicine

1 reference

20 August 2017

12

1 reference

20 August 2017

1

1 reference

20 August 2017

71-77

1 reference

https://scigraph.springernature.com/pub.10.1007/s12017-009-8076-z

20 August 2017

0 references

cites work

Conditions associated with Alzheimer's disease at death: case-control study.

1 reference

https://api.crossref.org/works/10.1007%2FS12017-009-8076-Z

Neurologic signs in Alzheimer's disease. Results of a prospective clinical and neuropathologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-009-8076-Z

Seizures and myoclonus in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-009-8076-Z

Dementia and adult-onset unprovoked seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-009-8076-Z

Myoclonic epilepsy of late onset in trisomy 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-009-8076-Z

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-009-8076-Z

Progressive myoclonus epilepsy in young adults with neuropathologic features of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-009-8076-Z

Seizures in Alzheimer's disease: clinicopathologic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-009-8076-Z

21 January 2018

Trisomy 21 and the brain

1 reference

https://api.crossref.org/works/10.1007%2FS12017-009-8076-Z

Advanced Alzheimer's disease is a risk factor for late-onset seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-009-8076-Z

A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-009-8076-Z

Epileptic pseudodementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-009-8076-Z

Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study.

21 January 2018

1 reference

12 December 2020

Behaviour, cognition and epilepsy

1 reference

12 December 2020

Epileptic seizures in clinically diagnosed Alzheimer's disease: report from a geriatric medicine population

1 reference

12 December 2020

Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models

1 reference

12 December 2020

Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy.

1 reference

12 December 2020

HDAC2 negatively regulates memory formation and synaptic plasticity.

1 reference

12 December 2020

Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease

1 reference

12 December 2020

Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: an update

1 reference

12 December 2020

Epilepsy presenting as AD: neuroimaging, electroclinical features, and response to treatment

1 reference

12 December 2020

CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy.

1 reference

12 December 2020

Transient epileptic amnesia in dementia: a treatable unrecognized cause of episodic amnestic wandering.

1 reference

12 December 2020

Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production

1 reference

12 December 2020

Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS).

1 reference

12 December 2020

Axonal sprouting and synaptogenesis in temporal lobe epilepsy: possible pathogenetic and therapeutic roles of neurite growth inhibitory factors

1 reference

12 December 2020

Senile myoclonic epilepsy in Down syndrome: a video and EEG presentation of two cases

1 reference

12 December 2020

Alzheimer's disease underlies some cases of complex partial status epilepticus

1 reference

12 December 2020

Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcome

1 reference

12 December 2020

Neuropsychological and behavioral effects of antiepilepsy drugs

1 reference

12 December 2020

Myoclonus, seizures, and paratonia in Alzheimer disease

1 reference

12 December 2020

Effect of seizures on progression of dementia of the Alzheimer type

1 reference

12 December 2020

Antiglutamatergic therapy in Alzheimer's disease--effects of lamotrigine. Short communication.

1 reference

12 December 2020

Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease

1 reference

12 December 2020

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

1 reference

12 December 2020

Can prolonged administration of valproic acid put patients with epilepsy at higher risk for development of Alzheimer's disease?

1 reference

12 December 2020

Seizures in elderly patients with dementia: epidemiology and management

1 reference

12 December 2020

Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease.

1 reference

12 December 2020

Cerebral biopsy in the investigation of presenile dementia due to cerebral atrophy

1 reference

12 December 2020

Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

1 reference

12 December 2020

Temporal lobe epileptic activity mimicking dementia: a case report

1 reference

12 December 2020

Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones

1 reference

12 December 2020

An African American family with early-onset Alzheimer disease and an APP (T714I) mutation

1 reference

12 December 2020

Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study.

1 reference

12 December 2020

Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene

1 reference

12 December 2020

Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo

1 reference

12 December 2020

Age of seizure onset in adults with Down's syndrome

1 reference

12 December 2020

Convulsions induced by donepezil

1 reference

12 December 2020

Memory disturbances and temporal lobe epilepsy simulating Alzheimer's disease: a case report.

1 reference

12 December 2020

Down syndrome, Alzheimer's disease and seizures

1 reference

12 December 2020

Lacosamide: a review of preclinical properties.

1 reference

12 December 2020

Senile myoclonic epilepsy of Genton: two cases in Down syndrome with dementia and late onset epilepsy.

1 reference

12 December 2020

A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease

1 reference

12 December 2020

Down syndrome in the neurology clinic: Too much? Too little? Too late?

1 reference

12 December 2020

Hippocampal atrophy may be a predictor of seizures in Alzheimer's disease.

1 reference

12 December 2020

Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer's disease.

1 reference

12 December 2020

Neuroinhibitory molecules in Alzheimer's disease

1 reference

12 December 2020

Late-onset temporal lobe epilepsy with unilateral mesial temporal sclerosis and cognitive decline: a diagnostic dilemma

1 reference

12 December 2020

Does epileptiform activity contribute to cognitive impairment in Alzheimer's disease?

1 reference

12 December 2020

Epileptic seizures in elderly patients with dementia.

1 reference

12 December 2020

Older adults with epilepsy demonstrate cognitive impairments compared with patients with amnestic mild cognitive impairment

1 reference

12 December 2020

The cortical neuritic dystrophy of Alzheimer's disease: nature, significance, and possible pathogenesis

1 reference

12 December 2020

Incidence and predictors of seizures in patients with Alzheimer's disease

1 reference

12 December 2020

Alzheimer's disease and senile dementia of Alzheimer type. A comparative study.

1 reference

12 December 2020

A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.

1 reference

12 December 2020

10.1007/S12017-009-8076-Z

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19557550